Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Cardiovascular Disease Monitoring and Diagnostic Devices
... the year 2023, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. ECG Systems, one of the segments analyzed in the report, is expected to ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Ovulation Test
... at a CAGR of 4.0% over the analysis period 2023-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Global Gait Analyzer Market Research Report 2024
... during the forecast period 2024-2030. In 2023 the Global Gait Analyzer production were 1,057 Units and it will be 1,908 Units in 2030, with a CAGR of 8.62% between 2024 and 2030. Europe and North ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... US$6.5 Billion in the year 2023, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic Braces & Supports, one of the segments analyzed in ... Read More
-
Women's Health Therapeutics
... Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 ... Read More
-
Xerostomia (Dry Mouth) Therapeutics
... reach US$1.0 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Over-the-Counter Xerostomia Drugs, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and ... Read More
-
Optical Coherence Tomography Market Report by Type (Handheld OCT Devices, Tabletop OCT Devices, and Others), Technology (Time Domain OCT (TDOCT), Frequency Domain OCT (FD-OCT)), Application (Dermatology, Ophthalmology, Cardiovascular, Oncology, and Others), and Region 2024-2032
... global optical coherence tomography market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.2% during 2024-2032. ... Read More
-
US Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032 US Esoteric Testing Market is valued approximately USD 6.87 Billion in 2023 and is anticipated to grow with a ... Read More
-
Bone Growth Stimulators
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stimulation Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$855.7 Million by ... Read More
-
Corporate Wellness
... at a CAGR of 6.6% over the analysis period 2023-2030. Small-scale Organizations End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$19.2 Billion by the end ... Read More
-
Interventional Radiology Systems
... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$12.7 Billion by ... Read More
-
Bulk Paclitaxel
... at a CAGR of 8.6% over the analysis period 2023-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$139.1 Million by the end ... Read More
-
Cardiovascular Drugs
... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Rheumatoid Arthritis Therapeutics
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Pharmaceuticals Molecule, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$28.0 Billion by ... Read More
-
Breast Cancer Therapeutics
... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by ... Read More
-
Cosmetic Procedures and Products
... reach US$60.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach ... Read More
-
Condoms
... of 5.8% over the analysis period 2023-2030. Natural Condoms, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. ... Read More
-
Prostate Cancer Therapeutics
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by ... Read More
-
Continuous Renal Replacement Therapy (CRRT)
... is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record ... Read More
-
Anxiety Disorder Treatment
... by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.9 Billion by the ... Read More
-
Autologous Matrix-Induced Chondrogenesis (AMIC)
... reach US$278.0 Million by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Collagen, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$158.8 ... Read More
-
Contract Research Organization Services (CROs)
... is expected to reach US$149.1 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a ... Read More
-
Botulinum Toxin
... at a CAGR of 8.8% over the analysis period 2023-2030. Type A Botulinum Toxin, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the ... Read More
Research Assistance
